Literature DB >> 4316020

Effect of arginine-deficient media on the herpes-type virus associated with cultured Burkitt tumor cells.

W Henle, G Henle.   

Abstract

After incubation at 37 C for 2 or more days, Basal Medium Eagle (BME) supplemented with 25% fetal calf serum (FCS) was not able to support adequate growth of EB3 and other lines of Burkitt tumor cells. The medium did, however, increase, by a factor of about 10, the number of cells synthesizing herpes-type virus with which the cultures were persistently infected. Not every lot of FCS produced these effects, nor were these effects seen when BME and FCS were incubated separately for 7 days before the medium was completed. At 37 C, appropriate lots of FCS interacted with several of the amino acids present in BME; this interaction resulted in an inhibition of cellular growth, whereas interaction with arginine yielded the virus-enhancing effect. Arginine-free BME, supplemented with 25% FCS and used without prior incubation, prevented cellular replication and promoted viral infection to a similar extent as did preincubated complete medium. Replenishment of arginine reduced, but did not regularly abolish, the virus-enhancing activity of preincubated media. RPMI-1629 medium was less affected by preincubation with FCS because it contained twice the amount of arginine that BME contained. The FCS factors which act upon arginine and other amino acids are not dialyzable and are partially resistant to heating at 56 or 60 C for 30 to 60 min. Calf and horse sera appear to be devoid of these activities. The nature of these interactions, as well as the mechanism by which arginine deficiency enhanced the viral infection, remains to be ascertained.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4316020      PMCID: PMC375599     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  BURKITT TUMOR: TISSUE CULTURE, CYTOGENETIC AND VIRUS STUDIES.

Authors:  S E STEWART; E LOVELACE; J J WHANG; V A NGU
Journal:  J Natl Cancer Inst       Date:  1965-02       Impact factor: 13.506

2.  [Nutritional factors influencing the growth of herpes virus in Earle's strain of L cells].

Authors:  J PELMONT; H R MORGAN
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-04

3.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

4.  Culture of normal human leukocytes.

Authors:  G E Moore; R E Gerner; H A Franklin
Journal:  JAMA       Date:  1967-02-20       Impact factor: 56.272

5.  Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells.

Authors:  W Henle; K Hummeler; G Henle
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

6.  Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells.

Authors:  J A Levy; G Henle
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

7.  Herpes-like particles in an American lymphoma: preliminary note.

Authors:  G T O'Connor; A S Rabson
Journal:  J Natl Cancer Inst       Date:  1965-11       Impact factor: 13.506

8.  Partial purification and electron microscopy of virus in the EB-3 cell line derived from a Burkitt lymphoma.

Authors:  I Toplin; G Schidlovsky
Journal:  Science       Date:  1966-05-20       Impact factor: 47.728

9.  Fine structure of a virus in cultured lymphoblasts from Burkitt lymphoma.

Authors:  K Hummeler; G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

10.  Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.

Authors:  W Henle; V Diehl; G Kohn; H Zur Hausen; G Henle
Journal:  Science       Date:  1967-09-01       Impact factor: 47.728

View more
  16 in total

1.  Growth of B95-8 cells and expression of Epstein-Barr virus lytic phase in serum-free medium.

Authors:  J E Shaw; R G Petit; K Leung
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Activation of herpes specific antigens and infectious virus in a hamster cell line transformed by HSV-2.

Authors:  L Váczi; I Boldogh; E Gönczöl
Journal:  Arch Gesamte Virusforsch       Date:  1974

3.  Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines.

Authors:  V Vonka; M Benyesh-Melnick; R T Lewis; I Wimberly
Journal:  Arch Gesamte Virusforsch       Date:  1970

4.  Proteins specified by herpes simplex virus. 3. Viruses differing in their effects on the social behavior of infected cells specify different membrane glycoproteins.

Authors:  J M Keller; P G Spear; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

5.  Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.

Authors:  Lyndle Gradoville; David Kwa; Ayman El-Guindy; George Miller
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  The role of lipoproteins in EBV early antigen induction in Raji cells.

Authors:  M Simon; I Melzner; B Bültmann
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Immunobiochemical characterization with monoclonal antibodies of Epstein-Barr virus-associated early antigens in chemically induced cells.

Authors:  A L Epstein
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

8.  Stimulation of Herpesvirus saimiri expression in the absence of evidence for type C virus activation in a marmoset lymphoid cell line.

Authors:  R H Neubauer; W C Wallen; H Rabin
Journal:  J Virol       Date:  1974-10       Impact factor: 5.103

9.  Reverse transcriptase-containing particles induced in rous sarcoma virus-transformed rat cells by arginine deprivation.

Authors:  M Kotler; E Weinberg; O Haspel; Y Becker
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

10.  Commentary: mechanistic considerations for associations between formaldehyde exposure and nasopharyngeal carcinoma.

Authors:  Chad M Thompson; Roland C Grafström
Journal:  Environ Health       Date:  2009-11-25       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.